Danish Health Authority awaits Danish study results before giving verdict on Astrazeneca

The EMA's Astrazeneca-related announcement will not influence the Danish pause of Astrazeneca vaccines.

Danish Health Authority Director General Søren Brostrøm | Photo: Jens Dresling/Ritzau Scanpix

The Danish Health Authority intends to wait until the Danish investigation of the Astrazeneca vaccine and possibly related rare cases of blood clots has been concluded before deciding whether Denmark will go back to using this particular vaccine, according to a press statement from the Danish Health Authority.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs